1 | 111jc101 | - | - | - | - | 1件: 25 25 💬
|
2 | 89 ZR-DF-crefmirlimab | - | - | - | - | 2件: 13 13, 25 💬
|
3 | Brain MRI | - | - | - | - | 3件: 8 8, 25, 229 💬
|
4 | CE-VST01-JC | 1件: CE-VST01-JC CE-VST01-JC | - | - | - | 1件: 25 25 💬
|
5 | Cidofovir | 1件: Cidofovir Cidofovir | 1件: Cidofovir
Cidofovir
💬
| - | - | 1件: 25 25 💬
|
6 | Collection OF blood and urine | - | - | - | - | 1件: 25 25 💬
|
7 | CYT107 | - | - | - | - | 1件: 25 25 💬
|
8 | Cytarabine | 1件: Cytarabine Cytarabine | 2件: Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | 7件: 11 11, 13, 14, 25, 34, 49, 60 💬
|
9 | Didanosine | 1件: Didanosine Didanosine | 1件: Didanosine
Didanosine
💬
| - | - | 2件: 25 25, 265 💬
|
10 | Enfuvirtide | 1件: Enfuvirtide Enfuvirtide | 1件: Enfuvirtide
Enfuvirtide
💬
| - | - | 2件: 25 25, 265 💬
|
11 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
12 | Interferon ALFA-2B | 2件: Interferon alfa Interferon alfa, Interferon alfa-2b | 2件: Interferon alfa-2b
Interferon alfa-2b
,
Interferon alfa
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 25 25 💬
|
13 | Lariam | 1件: Mefloquine Mefloquine | 2件: Mefloquine hydrochloride
Mefloquine hydrochloride
,
Mefloquine
💬
| - | - | 1件: 25 25 💬
|
14 | Mefloquine | 1件: Mefloquine Mefloquine | 2件: Mefloquine hydrochloride
Mefloquine hydrochloride
,
Mefloquine
💬
| - | - | 2件: 25 25, 46 💬
|
15 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
16 | Natalizumab | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 5件: 13 13, 15, 25, 46, 96 💬
|
17 | Neurological evaluation | - | - | - | - | 1件: 25 25 💬
|
18 | NT-I7 | 1件: Efineptakin alfa Efineptakin alfa | 1件: Efineptakin alfa
Efineptakin alfa
💬
| - | - | 1件: 25 25 💬
|
19 | Pembrolizumab | 1件: Pembrolizumab Pembrolizumab | 1件: Pembrolizumab
Pembrolizumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 25 25, 285 💬
|
20 | Pembrolizumab, 25 MG/ML solution FOR intravenous (IV) injection | 1件: Pembrolizumab Pembrolizumab | 1件: Pembrolizumab
Pembrolizumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 1件: 25 25 💬
|
21 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
22 | Probenecid | 1件: Probenecid Probenecid | 1件: Probenecid
Probenecid
💬
| - | - | 1件: 25 25 💬
|
23 | Pyvst | - | - | - | - | 1件: 25 25 💬
|
24 | Recombinant human interleukin-7 | - | - | - | - | 1件: 25 25 💬
|
25 | Spinal TAP | - | - | - | - | 1件: 25 25 💬
|
26 | Tenofovir-emtricitabine | 1件: Tenofovir Tenofovir | 1件: Tenofovir
Tenofovir
💬
| - | - | 1件: 25 25 💬
|
27 | Teriflunomide | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 25, 26, 63 💬
|
28 | Topotecan | 1件: Topotecan Topotecan | 2件: Topotecan hydrochloride
Topotecan hydrochloride
,
Topotecan
💬
| - | - | 1件: 25 25 💬
|
29 | Tysabri | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 3件: 13 13, 25, 63 💬
|
30 | Zalcitabine | 1件: Zalcitabine Zalcitabine | 1件: Zalcitabine
Zalcitabine
💬
| - | - | 1件: 25 25 💬
|
31 | Zidovudine | 1件: Zidovudine Zidovudine | 1件: Zidovudine
Zidovudine
💬
| - | - | 6件: 25 25, 26, 135, 265, 325, 331 💬
|